StubHub Holdings just delivered a Q1 print that beat on both lines — then watched the stock drop 3.4% the next session.
Revenue came in at $446 million against a $432 million estimate, and EPS of $0.06 beat the $0.02 consensus. Gross Merchandise Sales rose 7% to $2.2 billion. Management reiterated full-year GMS and EBITDA guidance, citing a healthy live-events calendar and the early momentum from new distribution tools, including an AI-powered self-serve listing platform for venue and team partners. None of it moved the stock upward. The shares fell to $7.32 on May 12, leaving them down 3.7% on the week despite being up 17% over the prior month.
The shorts are still there, but they're retreating
Short interest remains a meaningful presence, but the directional story is one of steady unwinding. SI hit 8.2% of the free float at last count — real, but down sharply from close to 9.9% back in early April, when positions ran to their highest levels since listing. Over the past month alone, estimated short interest has dropped roughly 17%. The borrow market tells a slightly more complex story. Cost to borrow nearly doubled over the past week to 1.14%, its highest level in a month, after sliding to a trough of 0.45% in early May. That mid-week spike likely reflects some repositioning around the earnings print, not a structural tightening — the longer-term trajectory for CTB has been downward since early April, when it was running above 2%. Availability, at 43%, is in tighter territory — fewer than half as many shares remain available to borrow as are currently out on loan — but that reading has been broadly stable for weeks. The ORTEX short score is running at 66, a level that reflects meaningful but not extreme short conviction, and it has edged down modestly from 67.5 at end of April. Positioning looks like it's gradually easing rather than pressing further.
The Street is cautious, and the valuation data is coherent with that view
Analysts are uniformly on hold. Eight of eight tracked recommendations are Neutral or equivalent — there are no active Buy ratings in the coverage universe. Following the Q4 2025 miss in March, which sent the stock down 12% on the day and 25% over five sessions, firms including JP Morgan and Wedbush both downgraded and slashed targets, with JP Morgan cutting from $22 to $10 and Wedbush moving from $18 to $10. Oppenheimer and Evercore maintained Outperform ratings but took targets down hard — from $20 to $12 and from $27 to $14 respectively. The most recent update (Guggenheim, late March) trimmed its target to $7.50, which effectively equals the current price. None of these changes are recent enough to reflect the Q1 beat. The mean price target of $12.56 implies roughly 72% upside to the current level, but that number is anchored in pre-Q1 estimates and should be treated as directional rather than precise. Valuation multiples are soft: EV/EBITDA is running near 7.4x, down about 0.4 turns over the past month, and the P/E sits at 10.4x. Factor scores are mixed — the EPS surprise rank is a perfect 100 (consistent with beating estimates) and the 30-day EPS momentum rank is at 90, both strong. But short score ranks in the 7th percentile universe-wide, meaning most stocks are less shorted, and the 90-day EPS momentum score is a weak 7, reflecting the recent history of misses and guidance cuts.
Insider selling continues at every level
The most persistent signal across recent months is that insiders are selling, not buying. On May 5, Founder and CEO Eric Baker sold 18,128 shares at $7.60, President Nayaab Islam sold 22,300 shares at the same price, and Principal Accounting Officer Scott Fitzgerald sold 1,683. This was the second round of sales within a month: on April 7, Baker, Islam, CFO Constance James, and CTO Artem Yegorov all sold in a coordinated cluster, with James alone offloading 16,797 shares. Net insider activity over the trailing 90 days shows $2.7 million in aggregate selling. The individual transaction values are modest relative to overall holdings — Baker still holds nearly 10% of shares outstanding — but the consistent rhythm across five named executives signals that no one inside is using the depressed share price as a buying opportunity. The lock-up period expiry in 2026, flagged in the analyst bear case, may explain some of this; management may simply be following a pre-arranged selling plan. Still, the consistency of the activity is the kind of detail the Street will notice.
What to watch next
The next earnings date is June 5, with Q2 2026 results expected after the close. The key question heading into that print is whether the new open-distribution product — the AI-powered distribution manager and direct integrations with primary ticketing platforms — shows early commercial traction, or whether it remains a narrative asset with no measurable revenue contribution. The Q4 2025 miss produced a 25% five-day drawdown; the Q1 beat produced a 3% decline. How the stock reacts to a reiterated full-year guide with limited new catalysts will be a useful calibration of where the marginal buyer's conviction actually sits.
See the live data behind this article on ORTEX.
Open STUB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.